Mohammad Shahar Yar (M Shahar Yar, M Shahar Yar, Mohammad S Yar)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Venues

Archiv der Pharmazie

Drug development research

Expert opinion on drug discovery

Expert opinion on therapeutic patents

Jamia Hamdard

Jamia Hamdard (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jamia Hamdard Aug 18 2003

India

Associate Professor :: Department of Pharmaceutical Chemistry

Meerut Institute of Engineering and Technology Feb 14 2001 - Aug 18 2003

India

Lecturer :: Pharmaceutical Technology

Jamia Hamdard

India

Lecturer (Ad hoc) :: Pharmaceutical Chemistry

Education History

Jamia Hamdard

India

PHD :: Department of Pharmaceutical Chemistry

Publications

Vivek K Gour, Shaikh Yahya, Mohammad Shahar Yar
Unveiling the chemistry of 1,3,4-oxadiazoles and thiadiazols: A comprehensive review. Archiv der Pharmazie (2023)
Gunjan Bhasker, Salahuddin Salahuddin, Dr Avijit Mazumder, Rajnish Kumar, Greesh Kumar, Mohamed Jawed Ahsan, Mohammad Shahar Yar, Fahad Khan, Bhupinder Kapoor
Hybrids of Benzimidazole-Oxadiazole: A New Avenue for Synthesis, Pharmacological Activity and Recent Patents for the Development of More Effective Ligands. Current organic synthesis (2023)
Kashif Haider, Subham Das, Alex Joseph, Mohammad Shahar Yar
An appraisal of anticancer activity with structure-activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A review. Drug development research 83 (4) (2022)
Kashif Haider, Kamal Ahmad, Abul Kalam Najmi, Subham Das, Alex Joseph, Mohammad Shahar Yar
Design, synthesis, biological evaluation, and in silico studies of 2-aminobenzothiazole derivatives as potent PI3Kα inhibitors. Archiv der Pharmazie 355 (10) (2022)
Vikas Pradhan, null Salahuddin, Rajnish Kumar, Avijit Mazumder, Mohammad Mustaqeem Abdullah, Mohammad Shahar Yar, Mohamed Jawed Ahsan, Zabih Ullah
Molecular Target Interactions of Quinoline Derivatives as Anticancer Agents: A Review. Chemical biology & drug design (2022)
Shaikh Yahya, Kashif Haider, Ankita Pathak, Akram Choudhary, Pooja Hooda, Mohd Shafeeq, Mohammad Shahar Yar
Strategies in synthetic design and structure-activity relationship studies of novel heterocyclic scaffolds as aldose reductase-2 inhibitors. Archiv der Pharmazie 355 (12) (2022)
Kashif Haider, Shivani Sharma, Yuba Raj Pokharel, Subham Das, Alex Joseph, Abul Kalam Najmi, Faiz Ahmad, Mohammad Shahar Yar
Synthesis, biological evaluation, and in silico studies of indole-tethered pyrazoline derivatives as anticancer agents targeting topoisomerase IIα. Drug development research 83 (7) (2022)
Kashif Haider, Anku Sharma, Mohammad Shahar Yar, Prasanna Anjaneyulu Yakkala, Syed Shafi, Ahmed Kamal
Novel approaches for the development of direct KRAS inhibitors: structural insights and drug design. Expert opinion on drug discovery 17 (3) (2022)
Kashif Haider, Sara Rehman, Ankita Pathak, Abul K Najmi, Mohammad Shahar Yar
Advances in 2-substituted benzothiazole scaffold-based chemotherapeutic agents. Archiv der Pharmazie 354 (12) (2021)
Rajeev Kharb, Kashif Haider, Kumari Neha, Mohammad Shahar Yar
Aromatase inhibitors: Role in postmenopausal breast cancer. Archiv der Pharmazie 353 (8) (2020)
Mohammad Shahar Yar, Kashif Haider, Vivek Gohel, Nasir Ali Siddiqui, Ahmed Kamal
Synthetic lethality on drug discovery: an update on cancer therapy. Expert opinion on drug discovery 15 (7) (2020)
Kashif Haider, Shaik Rahaman, Mohammad Shahar Yar, Ahmed Kamal
Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018). Expert opinion on therapeutic patents 29 (8) (2019)
Ankit Rohilla, Tanya Gupta, Ankita Pathak, Md J Akhtar, Md R Haider, Kashif Haider, Mohammad Shahar Yar
Emergence of promising novel DPP-4 inhibitory heterocycles as anti-diabetic agents: A review. Archiv der Pharmazie (2018)

Mohammad Shahar Yar.css-eqlu8i{font-size:small;padding-left:4px;} (M Shahar Yar, M Shahar Yar, Mohammad S Yar)

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammad Shahar Yar (M Shahar Yar, M Shahar Yar, Mohammad S Yar)